Literature DB >> 29932371

MicroRNAs in prostate cancer: From function to biomarker discovery.

Ahmed A Moustafa1, Hogyoung Kim2, Rasha S Albeltagy1, Ola H El-Habit1, Asim B Abdel-Mageed2,3.   

Abstract

MicroRNAs (miRNAs) are a small functional non-coding RNAs that post-transcriptionally regulate gene expression through mRNA degradation or translational repression. miRNAs are key regulatory components of various cellular networks. Current evidence support that multiple mammalian genome-encoded miRNAs impact the cellular biology, including proliferation, apoptosis, differentiation, and tumorigenesis, by targeting specific subsets of mRNAs. This minireview is focused on the current themes underlying the interactions between miRNAs and their mRNA targets and pathways in prostate tumorigenesis and progression, and their potential clinical utility as biomarkers for prostate cancer. Impact statement The primary goal of this article was to review recent literature on miRNA biogenesis and further elaborate on the identity of newly discovered miRNAs and their potential functional significance in the complex biological network associated with prostate tumorigenesis and disease progression and as biomarkers for prostate cancer.

Entities:  

Keywords:  Prostate cancer; biomarkers; microRNA; onco-miR; tumor suppressor miRNAs

Mesh:

Substances:

Year:  2018        PMID: 29932371      PMCID: PMC6022910          DOI: 10.1177/1535370218775657

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  103 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  Strategies to determine the biological function of microRNAs.

Authors:  Jan Krützfeldt; Matthew N Poy; Markus Stoffel
Journal:  Nat Genet       Date:  2006-06       Impact factor: 38.330

3.  Epithelial and stromal expression of miRNAs during prostate cancer progression.

Authors:  Qinghu Ren; Jiaqian Liang; Jianjun Wei; Olca Basturk; Jinhua Wang; Garrett Daniels; Lan Lin Gellert; Yirong Li; Ying Shen; Iman Osman; Jun Zhao; Jonathan Melamed; Peng Lee
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

4.  Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.

Authors:  Yen-Nien Liu; JuanJuan Yin; Ben Barrett; Heather Sheppard-Tillman; Dongmei Li; Orla M Casey; Lei Fang; Paul G Hynes; Amir H Ameri; Kathleen Kelly
Journal:  Mol Cell Biol       Date:  2015-03-23       Impact factor: 4.272

Review 5.  Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer.

Authors:  Baris Turkbey; Anna M Brown; Sandeep Sankineni; Bradford J Wood; Peter A Pinto; Peter L Choyke
Journal:  CA Cancer J Clin       Date:  2015-11-23       Impact factor: 508.702

6.  Widespread deregulation of microRNA expression in human prostate cancer.

Authors:  M Ozen; C J Creighton; M Ozdemir; M Ittmann
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

7.  Keratin immunoreactivity in the benign and neoplastic human prostate.

Authors:  M K Brawer; D M Peehl; T A Stamey; D G Bostwick
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

8.  miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

Authors:  Paolo Gandellini; Marco Folini; Nicole Longoni; Marzia Pennati; Mara Binda; Maurizio Colecchia; Roberto Salvioni; Rosanna Supino; Roberta Moretti; Patrizia Limonta; Riccardo Valdagni; Maria Grazia Daidone; Nadia Zaffaroni
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

9.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

10.  Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.

Authors:  William T Budd; Sarah J Seashols-Williams; Gene C Clark; Danielle Weaver; Valerie Calvert; Emanuel Petricoin; Ema A Dragoescu; Katherine O'Hanlon; Zendra E Zehner
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more
  8 in total

1.  Serum miRNAs are differentially altered by ethanol and caffeine consumption in rats.

Authors:  M Martinez; I M U Rossetto; R M S Arantes; F S N Lizarte; L F Tirapelli; D P C Tirapelli; L G A Chuffa; F E Martinez
Journal:  Toxicol Res (Camb)       Date:  2019-07-17       Impact factor: 3.524

2.  Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate.

Authors:  Julio Guilherme Balieiro Bernardes; Marianne Rodrigues Fernandes; Juliana Carla Gomes Rodrigues; Lui Wallacy Morikawa Souza Vinagre; Lucas Favacho Pastana; Elizabeth Ayres Fragoso Dobbin; Jéssyca Amanda Gomes Medeiros; Leonidas Braga Dias Junior; Gabriel Monteiro Bernardes; Izabel Maria Monteiro Bernardes; Ney Pereira Carneiro Dos Santos; Samia Demachki; Rommel Mario Rodriguez Burbano
Journal:  Genes (Basel)       Date:  2022-03-30       Impact factor: 4.141

3.  Correlation between blood levels of cadmium and lead and the expression of microRNA-21 in Egyptian bladder cancer patients.

Authors:  Amira Awadalla; Wael I Mortada; Hassan Abol-Enein; Ahmed A Shokeir
Journal:  Heliyon       Date:  2020-12-05

4.  Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression.

Authors:  Maija Puhka; Lisse Thierens; Daniel Nicorici; Tarja Forsman; Tuomas Mirtti; Taija Af Hällström; Elina Serkkola; Antti Rannikko
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

5.  Integrated analysis of mRNA-single nucleotide polymorphism-microRNA interaction network to identify biomarkers associated with prostate cancer.

Authors:  Zhiwen Wang; Xi Zhu; Hongyun Zhai; Yanghai Wang; Gangyue Hao
Journal:  Front Genet       Date:  2022-07-25       Impact factor: 4.772

6.  Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer.

Authors:  Duran Canatan; Ozlem Yılmaz; Yonca Sonmez; Abdullah Cim; Mehmet Baykara; Murat Savas; Hasan Senol Coskun; Sema Sezgin Goksu; Mehmet Rıfkı Aktekin
Journal:  Acta Biomed       Date:  2022-07-01

7.  MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway.

Authors:  Jie Situ; Hao Zhang; Zi Jin; Ke Li; Yunhua Mao; Wentao Huang
Journal:  Onco Targets Ther       Date:  2020-05-18       Impact factor: 4.147

8.  MicroRNA-92a Inhibits the Cell Viability and Metastasis of Prostate Cancer by Targeting SOX4.

Authors:  Guolong Liao; Haiyun Xiong; Jiani Tang; Yamei Li; Ying Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.